Hide metadata

dc.date.accessioned2024-02-10T17:50:28Z
dc.date.available2024-02-10T17:50:28Z
dc.date.created2023-12-13T12:37:02Z
dc.date.issued2023
dc.identifier.citationElster, Christin Ommer-Bläsius, Miriam Lang, Alexander Vajen, Tanja Pfeiler, Susanne Feige, Milena Yau Pang, Tin Böttenberg, Marius Verheyen, Sarah Le Quy, Khang Chernigovskaia, Maria Kelm, Malte Winkels, Holger Schmidt, Susanne V. Greiff, Victor Gerdes, Norbert . Application and challenges of TCR and BCR sequencing to investigate T- and B-cell clonality in elastase-induced experimental murine abdominal aortic aneurysm. Frontiers in Cardiovascular Medicine. 2023, 10:1221620, 1-15
dc.identifier.urihttp://hdl.handle.net/10852/107820
dc.description.abstractBackground An abdominal aortic aneurysm (AAA) is a life-threatening cardiovascular disease. Although its pathogenesis is still poorly understood, recent evidence suggests that AAA displays autoimmune disease characteristics. Particularly, T cells responding to AAA-related antigens in the aortic wall may contribute to an initial immune response. Single-cell RNA (scRNA) T cell receptor (TCR) and B cell receptor (BCR) sequencing is a powerful tool for investigating clonality. However, difficulties such as limited numbers of isolated cells must be considered during implementation and data analysis, making biological interpretation challenging. Here, we perform a representative single-cell immune repertoire analysis in experimental murine AAA and show a reliable bioinformatic processing pipeline highlighting opportunities and limitations of this approach. Methods We performed scRNA TCR and BCR sequencing of isolated lymphocytes from the infrarenal aorta of male C57BL/6J mice 3, 7, 14, and 28 days after AAA induction via elastase perfusion of the aorta. Sham-operated mice at days 3 and 28 and non-operated mice served as controls. Results Comparison of complementarity-determining region (CDR3) length distribution of 179 B cells and 796 T cells revealed neither differences between AAA and control nor between the disease stages. We found no clonal expansion of B cells in AAA. For T cells, we identified several clones in 11 of 16 AAA samples and one of eight control samples. Immune receptor repertoire comparison indicated that only a few clones were shared between the individual AAA samples. The most frequently used V-genes in the TCR beta chain in AAA were TRBV3, TRBV19, and the splicing variant TRBV12-2 + TRBV13-2. Conclusion We found no clonal expansion of B cells but evidence for clonal expansion of T cells in elastase-induced AAA in mice. Our findings imply that a more precise characterization of TCR and BCR distribution requires a more extensive number of lymphocytes to prevent undersampling and potentially detect rare clones. Thus, further experiments are necessary to confirm our findings. In summary, this paper examines TCR and BCR sequencing results, identifies limitations and pitfalls, and offers guidance for future studies.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleApplication and challenges of TCR and BCR sequencing to investigate T- and B-cell clonality in elastase-induced experimental murine abdominal aortic aneurysm
dc.title.alternativeENEngelskEnglishApplication and challenges of TCR and BCR sequencing to investigate T- and B-cell clonality in elastase-induced experimental murine abdominal aortic aneurysm
dc.typeJournal article
dc.creator.authorElster, Christin
dc.creator.authorOmmer-Bläsius, Miriam
dc.creator.authorLang, Alexander
dc.creator.authorVajen, Tanja
dc.creator.authorPfeiler, Susanne
dc.creator.authorFeige, Milena
dc.creator.authorYau Pang, Tin
dc.creator.authorBöttenberg, Marius
dc.creator.authorVerheyen, Sarah
dc.creator.authorLe Quy, Khang
dc.creator.authorChernigovskaia, Maria
dc.creator.authorKelm, Malte
dc.creator.authorWinkels, Holger
dc.creator.authorSchmidt, Susanne V.
dc.creator.authorGreiff, Victor
dc.creator.authorGerdes, Norbert
cristin.unitcode185,53,18,12
cristin.unitnameAvdeling for immunologi og transfusjonsmedisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2212964
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Frontiers in Cardiovascular Medicine&rft.volume=10:1221620&rft.spage=1&rft.date=2023
dc.identifier.jtitleFrontiers in Cardiovascular Medicine
dc.identifier.volume10
dc.identifier.doihttps://doi.org/10.3389/fcvm.2023.1221620
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2297-055X
dc.type.versionPublishedVersion
cristin.articleid122162


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International